PDS Biotechnology Corp. (PDSB)
1.10
+0.04
(+3.77%)
USD |
NASDAQ |
Jun 11, 14:42
PDS Biotechnology Total Assets (Quarterly) : 24.66M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 24.66M |
| December 31, 2025 | 30.53M |
| September 30, 2025 | 34.71M |
| June 30, 2025 | 40.48M |
| March 31, 2025 | 47.03M |
| December 31, 2024 | 45.36M |
| September 30, 2024 | 52.45M |
| June 30, 2024 | 60.50M |
| March 31, 2024 | 69.01M |
| December 31, 2023 | 59.39M |
| September 30, 2023 | 57.19M |
| June 30, 2023 | 63.75M |
| March 31, 2023 | 68.45M |
| December 31, 2022 | 77.01M |
| September 30, 2022 | 74.89M |
| June 30, 2022 | 56.00M |
| March 31, 2022 | 61.04M |
| December 31, 2021 | 67.20M |
| September 30, 2021 | 71.75M |
| June 30, 2021 | 77.39M |
| March 31, 2021 | 27.76M |
| December 31, 2020 | 30.89M |
| September 30, 2020 | 34.45M |
| June 30, 2020 | 20.09M |
| March 31, 2020 | 23.93M |
| Date | Value |
|---|---|
| December 31, 2019 | 14.49M |
| September 30, 2019 | 19.38M |
| June 30, 2019 | 25.80M |
| March 31, 2019 | 31.05M |
| December 31, 2018 | 0.1644M |
| September 30, 2018 | 37.67M |
| June 30, 2018 | 47.21M |
| March 31, 2018 | 76.61M |
| December 31, 2017 | 92.62M |
| September 30, 2017 | 101.24M |
| June 30, 2017 | 112.99M |
| March 31, 2017 | 99.90M |
| December 31, 2016 | 110.91M |
| September 30, 2016 | 116.58M |
| June 30, 2016 | 115.42M |
| March 31, 2016 | 123.77M |
| December 31, 2015 | 134.09M |
| September 30, 2015 | 58.48M |
| June 30, 2015 | 62.69M |
| March 31, 2015 | 15.92M |
| December 31, 2014 | 17.05M |
| September 30, 2014 | 5.553M |
| June 30, 2014 | |
| March 31, 2014 | 7.119M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 198.49M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Savara, Inc. | 221.64M |
| Vericel Corp. | 485.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.77M |
| Shareholders Equity (Quarterly) | 3.893M |
| Debt to Equity Ratio | 4.075 |
| Current Ratio | 2.256 |
| Net Debt Paydown Yield | 3.53% |